Regeneron's Sanofi deal finally turns a profit, thanks to Dupixent | Fierce Pharma
Sanofi to Join Regeneron in Quest to Unleash Immune System on Cancer - The New York Times
Comprendre l'inflammation de type 2
Meet Our National Sponsors: AbbVie, maker of HUMIRA & The Sanofi and Regeneron alliance.
Sanofi revises immuno-oncology deal with Regeneron
Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data | SaltWire
Sanofi et Regeneron révisent leur partenariat
Brevets: pourquoi plusieurs laboratoires se mêlent de la guerre entre Sanofi et Amgen
Sanofi, Regeneron uncouple on long-standing drug partnership, splitting up Praluent, Kevzara | Fierce Pharma
Industry Participation | ESMO
Successful Partnership Between Sanofi and Regeneron - YouTube
En Direct des Marchés : TotalEnergies, Sanofi, Apple, Alphabet, Amazon, Ford, Zur Rose... - 03/02/2023 | Zonebourse
Sanofi et Alnylam mettent fin à leur collaboration | Les Echos
Sanofi pourrait récolter plus de 13 Md$ en cédant des actions Regeneron | Capital Finance
Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data | Reuters
Regeneron purchases exclusive rights to Libtayo from Sanofi for $900M
Regeneron/Sanofi get EU okay for Dupixent in “asthma of the sinuses” | pharmaphorum
Emmanuel Barbarin - Head of Sanofi-Regeneron alliance controlling for Sanofi Industrial Affairs - Sanofi | LinkedIn
Regeneron and Sanofi Share First Positive Clinical Data for Cemiplimab in Advanced Non-small Cell Lung Cancer at ASCO - Pharma Advancement
Alnylam swaps Sanofi for Regeneron as R&D partner - PMLiVE
Sanofi, Regeneron expand testing of potential coronavirus treatment
Pharmacie: Sanofi annonce la vente de sa part dans Regeneron - L'Express
Sanofi, Regeneron to restructure antibody alliance for Kevzara, Praluent
Sanofi a mis en place une stratégie pour accélérer sa croissance - Capital.fr
Patentstreit: Sanofi vs. Amgen: Muss Praluent sofort vom Markt?
Sanofi pays Regeneron $462M to exit immuno-oncology R&D pact | Fierce Biotech
Le géant Sanofi annonce la vente de sa part dans Regeneron évaluée à environ 12 milliards d'euros
